[1] Care of injection drug users with soft tissue infections in San Francisco, California

[2] Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006

[3] Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009

[4] Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004

[5] Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites

[6] The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

[7] A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs

[8] HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection

[9] Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland

[10] Self-reported hepatitis C virus antibody status and risk behavior in young injectors

[11] Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services

[12] The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users

[13] Changes in blood-borne infection risk among injection drug users

[14] Inappropriate antibiotic use in soft tissue infections

[15] From the Centers for Disease Control and Prevention. Soft tissue infections among injection drug users--San Francisco, California, 1996-2000

[16] Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco

[17] Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy

[18] Tetanus surveillance--United States, 1998--2000

[19] the drug court pharmacist: expanding pharmacy practice and addressing substance abuse

[20] binge drinking and psychoactive drug use in a cohort of european youths

[21] the study of personality in addicts and normal group with due attention to gender

[22] Botulism in a pregnant intravenous drug abuser

[23] Wound botulism in California, 1951-1998: recent epidemic in heroin injectors

[24] Belgian experience with direct acting antivirals in people who inject drugs

[25] Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals

[26] Outbreak among drug users caused by a clonal strain of group A streptococcus

[27] Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs: Findings from the Queensland Injectors' Health Network

[28] Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment

[29] Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial

[30] Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs

[31] Limited uptake of hepatitis C treatment among injection drug users

[32] Wound botulism associated with black tar heroin among injecting drug users

[33] Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis

[34] Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003

[35] Gabapentin prescribed during substance abuse treatment: The perspective of treatment providers.

[36] Organizational and client determinants of cost in outpatient substance abuse treatment.

[37] Current status and future prospects for the development of substance abuse vaccines.

[38] Changes in Substance Abuse and HIV Risk Behaviors over 12-Month Methadone Maintenance Treatment among Vietnamese Patients in Mountainous Provinces.

[39] Perception among medical students in Riyadh, Saudi Arabia, regarding alcohol and substance abuse in the community: a cross-sectional survey

[40] Likelihood of Substance Abuse for Dyslexics May Be Influenced by Socioeconomic Background and Metacognition

[41] Relationship between parental communication patterns and self-efficacy in adolescents with parental substance abuse

[42] Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16

[43] Toward Increasing Engagement in Substance Use Data Collection: Development of the Substance Abuse Research Assistant App and Protocol for a Microrandomized Trial Using Adolescents and Emerging Adults

[44] acute pseudohepatitis in a chronic substance abuser secondary to occult seat belt injury

[45] trait mindfulness, reasons for living and general symptom severity as predictors of suicide probability in males with substance abuse or dependence.

[46] the comparison of alexithymia and emotions control among substance abusers and healthy people

[47] save generation from substance abuse

[48] neonatal effects of substance abuse during pregnancy

[49] the prediction of tendency to substance abuse on the basis of self esteem and components of emotional intelligence

[50] on the relationship of cognitive emotion regulation, self-efficacy, impulsiveness, and social skills with substance abuse in adolescents

[51] the drug court pharmacist: expanding pharmacy practice and addressing substance abuse

[52] Predictor Relations between Owned Values, Self-Efficacy for Protecting from Substance Abuse and Future Expectations among Adolescents

[53] a study of personality profile and criminal behavior in substance abusers

[54] health and social consequences of substance abuse

[55] pattern and trend of substance abuse in eastern rural iran: a household survey in a rural community

[56] volatile substance abuse via inhalation: clinical and demographical findings

[57] Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder (ADHD) Decreases the Risk for Substance Abuse: Findings From a Longitudinal Follow-Up of Youths With and Without ADHD

[58] Childhood Stimulant Treatment and Risk for Later Substance Abuse